These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34842611)

  • 1. Validation of a Custom Next-Generation Sequencing Assay for Cystic Fibrosis Newborn Screening.
    Sicko RJ; Stevens CF; Hughes EE; Leisner M; Ling H; Saavedra-Matiz CA; Caggana M; Kay DM
    Int J Neonatal Screen; 2021 Nov; 7(4):. PubMed ID: 34842611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.
    Skov M; Baekvad-Hansen M; Hougaard DM; Skogstrand K; Lund AM; Pressler T; Olesen HV; Duno M
    Pediatr Pulmonol; 2020 Feb; 55(2):549-555. PubMed ID: 31682332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study.
    Baker MW; Atkins AE; Cordovado SK; Hendrix M; Earley MC; Farrell PM
    Genet Med; 2016 Mar; 18(3):231-8. PubMed ID: 25674778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
    Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
    J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
    Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.
    Sommerburg O; Lindner M; Muckenthaler M; Kohlmueller D; Leible S; Feneberg R; Kulozik AE; Mall MA; Hoffmann GF
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S263-71. PubMed ID: 20714932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Sensitivity of Cystic Fibrosis Mutation Panels in a Diverse Population.
    Hughes EE; Stevens CF; Saavedra-Matiz CA; Tavakoli NP; Krein LM; Parker A; Zhang Z; Maloney B; Vogel B; DeCelie-Germana J; Kier C; Anbar RD; Berdella MN; Comber PG; Dozor AJ; Goetz DM; Guida L; Kattan M; Ting A; Voter KZ; ; van Roey P; Caggana M; Kay DM
    Hum Mutat; 2016 Feb; 37(2):201-8. PubMed ID: 26538069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Status of Genetic Diagnosis Laboratories and Frequency of Genetic Variants Associated with Cystic Fibrosis through a Newborn-Screening Program in Turkey.
    Bozdogan ST; Mujde C; Boga I; Sonmezler O; Hanta A; Rencuzogullari C; Ozcan D; Altintas DU; Bisgin A
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities.
    McGarry ME; Sciortino S; Graham S; Bishop T; Gibb ER
    Pediatr Pulmonol; 2024 Jun; ():. PubMed ID: 38940324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racially equitable diagnosis of cystic fibrosis using next-generation DNA sequencing: a case report.
    Shum BOV; Bennett G; Navilebasappa A; Kumar RK
    BMC Pediatr; 2021 Mar; 21(1):154. PubMed ID: 33789612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis.
    Ooi CY; Sutherland R; Castellani C; Keenan K; Boland M; Reisman J; Bjornson C; Chilvers MA; van Wylick R; Kent S; Price A; Mateos-Corral D; Hughes D; Solomon M; Zuberbuhler P; Brusky J; Durie PR; Ratjen F; Gonska T
    BMC Pediatr; 2019 Oct; 19(1):369. PubMed ID: 31640630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis newborn screening: the importance of bloodspot sample quality.
    Doull I; Course CW; Hanks RE; Southern KW; Forton JT; Thia LP; Moat SJ
    Arch Dis Child; 2021 Mar; 106(3):253-257. PubMed ID: 32859613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis newborn screening: using experience to optimize the screening algorithm.
    Hale JE; Parad RB; Dorkin HL; Gerstle R; Lapey A; O'Sullivan BP; Spencer T; Yee W; Comeau AM
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S255-61. PubMed ID: 20521170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes.
    Kay DM; Sadeghi H; Kier C; Berdella M; DeCelie-Germana JK; Soultan ZN; Goetz DM; Caggana M; Fortner CN; Giusti R; Kaslovsky R; Stevens C; Voter K; Welter JJ; ; Langfelder-Schwind E
    Pediatr Pulmonol; 2024 May; ():. PubMed ID: 38695616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two years of newborn screening for cystic fibrosis in Turkey: Çukurova experience.
    Şaşihüseyinoğlu AŞ; Altıntaş DU; Bişgin A; Doğruel D; Yılmaz M; Serbes M
    Turk J Pediatr; 2019; 61(4):505-512. PubMed ID: 31990467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
    Corbetta C; Seia M; Bassotti A; Ambrosioni A; Giunta A; Padoan R
    J Med Screen; 2002; 9(2):60-3. PubMed ID: 12133923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols.
    Gregg RG; Wilfond BS; Farrell PM; Laxova A; Hassemer D; Mischler EH
    Am J Hum Genet; 1993 Mar; 52(3):616-26. PubMed ID: 7680526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CFTR variant profile of Hispanic patients with cystic fibrosis: Impact on access to effective screening, diagnosis, and personalized medicine.
    Januska MN; Marx L; Walker PA; Berdella MN; Langfelder-Schwind E
    J Genet Couns; 2020 Aug; 29(4):607-615. PubMed ID: 32227567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.